Funding Announcements
Week of Aug. 19
ACS Multiple Endocrine Neoplasia (MEN2) Thyroid Cancer Consortium
Deadline: Oct. 15
More information
The American Cancer Society MEN2 Thyroid Cancer Consortium announces a new RFA applicable to Research Scholars/Mentored Research Scholars/Postdoctoral Fellows
Multiple Endocrine Neoplasia (MEN) is a syndrome involving tumors in two or more endocrine tissues. There are six described MEN syndromes and MEN type 2 (MEN2) is one of the most prevalent. It is associated with high levels of the hormone calcitonin, with tumors of the thyroid, adrenal gland and nervous tissue and mutations in the gene RET. While research has illuminated some aspects of MEN2, more research is needed before the syndrome can be effectively controlled.
The American Cancer Society has received a generous gift to further our understanding of MEN2 and improve diagnosis and treatment of MEN2 patients. As a result of this gift, the American Cancer Society announces this Request for Applications for the American Cancer Society MEN2 Thyroid Cancer Consortium. The scope of research in this Consortium will cover all aspects of MEN2-related cancer research. While the consortium will focus on the function of RET as an oncogene, appropriate areas of investigation include, but are not limited to: understanding consequences of RET mutations, and the molecular events underlying the development of MEN2-related (thyroid and other) tumors, improved animal models of MEN2, new screening and monitoring tools, new imaging approaches, and new pharmacologic and other strategies to blunt the effects of RET mutations.
RSG Qualifications: Individuals applying for a Research Scholar Grant must have an independent research or faculty position, be within six years of their first independent research or faculty appointment at the time of application, and may not already have substantial grant support. Projects in basic, preclinical, clinical, and epidemiology research are encouraged. Awards are for up to 5 years and for as much as $200,000 per year (direct costs), plus 20% allowable indirect costs.
MRSG Qualifications: Mentored Research Scholar Grants will be awarded to junior faculty members with a doctoral degree in a clinical or cancer control research discipline (e.g., M.D., and/or Ph.D.) that are within the first four years of a full time faculty appointment or equivalent, and have no more than 4 years of postdoctoral research experience immediately prior to their faculty appointment. The successful applicant is expected to acquire the research training, mentoring and experience necessary for transition into a successful career as an independent investigator. Awards are for up to five years and for up to $135,000 per year (direct costs), plus 8% allowable indirect costs. A maximum of $10,000 per year for the mentor(s) (regardless of the number of mentors) is included in the $135,000.
Postdoctoral Fellow Qualifications: Applicants must have obtained their doctoral degree prior to activation of the fellowship. Awards are for three years with progressive stipends of $40,000, $42,000, and $44,000 per year, plus a $4,000 per year institutional allowance. Individuals who have held a PhD or MD for more than 4 years at the time of application are not eligible.
American Cancer Society New Initiatives and RFA in Palliative Care
Deadline: October 15
More Information
POSTDOCTORAL FELLOWSHIP
This mechanism is designed to provide initial funding that will lead to an independent career in research. Eligibility: It is open to researchers who have received a doctoral degree and do not have a faculty appointment yet. Funding: is available for up to 3 years with progressive stipends of $40,000, $42,000 and $44,000 per year, plus a $4,000 per year fellowship allowance. Application deadline: October 15th 2008. For details please go to www.cancer.org → Research Programs and Funding→ Funding Opportunities → Postdoctoral Fellowship Policies and Instructions.
MENTORED RESEARCH SCHOLAR GRANT
This mechanism is intended to support mentored research for full time faculty with the goal of becoming independent researchers. Eligibility: Open to faculty typically in the first 4 years of their first independent position. Faculty who are over 4 years in an independent position but are changing career tracks to research may be eligible to apply. Funding: is available for up to 5 years and up to $135,000 per year plus 8% allowable indirect costs. Application deadline: October 15th, 2008. For details please go to www.cancer.org → Research Programs and Funding→ Funding Opportunities → Mentored Research Scholar Grant Policies and Instructions.
RESEARCH SCHOLAR GRANT
This mechanism is intended to support researchers conducting independent research. Eligibility: Open to independent researchers in the first 6 years from date of their first independent position. There is one exception: Investigators at any stage of their career may apply if the study focuses on underserved populations with the goal of reducing disparities. Funding is available for up to 4 years (5 years if focusing on underserved populations) and up to $200,000 per year ($400,000 per year if focusing on underserved populations) and 20% indirect costs. Application deadline: October 15th, 2008. For details please go to www.cancer.org → Research Programs and Funding→ Funding Opportunities → Research Scholar Grant Policies and Instructions.
RFA: PILOT AND EXPLORATORY PROJECTS IN PALLIATIVE CARE
This special initiative supports pilot and exploratory studies in palliative care that test interventions, explore novel areas of research and develop research methodologies.
This RFA is limited to applications that focus on palliative care research projects for seriously ill cancer patients and their families in three specific areas:
1. Exploring the relationship of pain and other distressing symptoms on quality and quantity of life, independence, function, and disability and developing interventions directed at their treatment in patients with advanced and chronic illinesses;
2. Studying methods of improving communication between adults living with serious illness, their families and their health care providers;
3. Evaluating models and systems of care for patients living with advanced illness and their families.
As a condition of accepting the award, each recipient of this grant, will agree to:
1. Attend the required meetings of the NPCRC in September, 2009;
2. Present results of the funded research at this required NPCRC meetng;
3. Prepare annual progress reports for each year of funding and a final report at the conclusion of the award period.
4. List the American Cancer Society as funding this study on all publications and presentations.
ELIGIBILITY REQUIREMENTS:
1. Applications may be submitted by not-for-profit institutions located within the United States, its territories and the Commonwealth of Puerto Rico.
2. Applicants must be United States citizens, non-citizen nationals or permanent residents of the United States.
3. Applicants must hold a doctorate degree (MD, PhD, or equivalent) and have a full-time faculty position or equivalent at a college, university, medical school, or other fiscally responsible not-for-profit organization within the United States. Independent investigators at all stages of their career are eligible to apply. Thus, the usual ACS restriction to investigators within the first six years of their initial independent research appointment does not apply to this RFA.
MECHANISM OF SUPPORT: Mechanism: This RFA will use the American Cancer Society Pilot and Exploratory Projects (PEP) award mechanism. Complete instructions on this grant mechanism can be found here Pilot and Exploratory Projects in Palliative Care of Cancer Patients and Their Families Policies and Instructions. Length of Study: Awards may not exceed a period of one to two years duration. Budget: Awards may not exceed $60,000 per year (direct costs) plus 20% indirect costs. Salary support for the Principal Investigator may not exceed 20% of the direct costs.
Awards: It is anticipated that a total of $500,000 will be available for 5 to 7 applications selected through the Society's peer review program.
Charlotte Geyer Foundation Funding Opportunity
Deadline: November 15, 2008
More Information and Application
The Charlotte Geyer Foundation provides interim funding up to $100,000 to researchers who have submitted an original R01 or R21 proposal to the National Cancer Institute and have not received a fundable score.
The Charlotte Geyer Foundation supports research into the cause, prevention and treatment of cancer. The Foundation reviews proposals three times per year and awards grants up to $100,000 each. The Charlotte Geyer Foundation award is for a single resubmission. The award cannot run concurrently with other funding for the same project, therefore distribution of the award is made in increments throughout the granting period.
Pediatric Cancer Research Foundation
Deadline: May 1, 2008
More information
Grants available in: Stem cell transplantation, Stem cell biology, Molecular oncology, and Molecular and cell genetics.
The Pediatric Cancer Research Foundation gives $1.1 million in research grants per year. It pays NO overhead or indirect costs. It is focused on improving the care, quality of life and survival rates of children with malignant diseases. It concentrates on supporting laboratory research that will translate into immediate treatment for children with cancer. It funds research that brings innovative new drugs and treatment regimens to children.
Grant Application: http://www.pcrf-kids.com/PCRF_grantApplication.pdf
National Palliative Care Research Center Pilot and Exploratory Project Support Grant
Letter of Intent Deadline: November 1
More Information
The Pilot/Exploratory Project Support Grant Program provides funding for investigators performing pilot/exploratory research studies that focus on improving care for seriously ill patients and their families. Investigators must conduct research projects whose purpose is to test interventions, develop research methodologies, and explore novel areas of research that are directly related to the Center's core mission and stated 3 areas of interest. A condition of funding is a clearly defined plan as to how the investigator will use the results of the project to develop larger, extramurally funded research projects.
AWARD INFORMATION
Awards may be for one to two years in duration and for as much as $70,000 per year (direct costs), plus 10% allowable indirect costs. Start date for all awards will be July 1, 2009.
Junior Faculty Career Development Award
One of the major barriers to the growth of the field of palliative care is the lack of a pipeline for the development of scientific investigators. Given the low levels of support for research focusing on the care of people with serious and complex illness, new investigators are at a significant disadvantage in competing for larger, externally funded project and career development awards because of an absence of pilot data to support their grants and the absence of a publication track record in research. Historically, externally funded research by senior investigators has cross-subsidized mentoring and pilot studies for their mentees, however, downwardly negotiated budgets, the expectation of contributed time on the part of funders, reduced indirect costs, and the reluctance of institutions to support contributed time, have all made such cross-subsidization increasingly difficult.
The National Palliative Care Research Center (NPCRC) is providing Junior Faculty Career Development Awards to allow junior faculty to have the protected time required to develop and conduct the pilot research necessary to be competitive for larger, extramurally funded awards. Proposed research must focus on improving care for patients with serious illness and their families in one of the three NPCRC key areas of interest: pain and symptom management, communication, and models of care for palliative care delivery.
AWARD INFORMATION
The Junior Faculty Career Development Award provides two years of support for salary and/or research activities to junior faculty in the amount of $70,000 per year (direct costs), plus 10% allowable indirect costs. Awards are not renewable. Start date for all awards will be July 1, 2009.
Week of Aug. 12
Southwest Oncology Group Coltman Fellowships (2008/2009)
Deadline: Sept. 5, 5 pm
Dr. Charles Coltman, Jr. Clinical Fellowship
The primary purpose of the Dr. Charles A. Coltman, Jr. Fellowship is to engage outstanding young investigators from SWOG member institutions in independent research, while honoring the retirement of long time SWOG chair and leader, Dr. Charles Coltman.
This program supports investigators from a current SWOG member institution who have accepted a faculty position. Institutions may nominate up to two candidates annually. The applicant must have a mentorship arrangement with a notable Group leader who has proven expertise in clinical trials recruitment and management.
Following review of the applications, the successful Fellow is then selected by an independent panel of SWOG Executive Officers and disease committee leadership. The fellowship provides $100,000 over two years and requires detailed annual progress reports of how the Fellow has utilized the funding to further his or her cancer clinical research.
For details and application form, see the Charles A. Coltman, Jr., M.D., Fellowship Announcement.
Charles A. Coltman, Jr., MD Fellowship in Translational Medicine
An extension of the general Coltman Fellowship program, the Fellowship Program in Translational Medicine is built upon Dr. Coltman's longstanding commitment to promoting the impact of research from bench to bedside, directly applying important research findings to improve patient care.
This program similarly supports investigators from a current SWOG member institution who have accepted a faculty position, with institutions able to nominate up to two candidates annually. The applicant must have a mentorship arrangement with a notable Group leader who has proven expertise in Translational Medicine research, clinical trials recruitment and management.
The successful Fellow is then selected by an independent panel of SWOG Executive Officers and disease committee leadership.
The fellowship provides $100,000 over two years and requires annual detailed progress reports setting forth how the funding has enabled the Fellow's Translational Medicine knowledge and initiatives.
For details and application form, see the Charles A. Coltman, Jr., M.D., Translational Medicine Fellowship Announcement.
Susan G Komen for the Cure Promise Grants
Pre-Application Deadline: Sept. 25
More details
Susan G. Komen for the Cure is excited to announce the release of Promise Grants for the 2008-2009 Research Program. The Request for Applications (RFA) is now available on the website.
Promise Grants provide up to $1.5M annually over five years to support programs with collaborative and cross-disciplinary research projects that provide integrated approaches to solving critical challenges to the rapid translation of scientific discoveries into new or enhanced clinical tools and applications that have the greatest potential to significantly reduce breast cancer incidence and/or mortality within the next decade. Integrated programs of research projects addressing critical challenges in population disparities in breast cancer outcomes and triple negative breast cancer are of special interest and may receive funding priority. Pre-applications are required prior to starting a full application.
Week of Aug. 5
Grants for "From Hypothesis to Product" Diagnostic Development Tutorial
Deadline: Aug 15.
More Information For early-career physicians and scientists within 8 years of a faculty appointment at an academic institution. The tutorial is organized by ASCO, NCI and EORTC in conjunction with the ASCO-NCI-EORTC Annual Meeting on Molecular Markers in Cancer, Oct. 30-Nov. 1 in Hollywood, FL. The tutorial is Oct. 29-30. It is designed to address critical issues that must be considered when developing new tools to aid clinical decision-making for patients with cancer. To apply:
- Submit your CV
- Indicate your membership affiliation (EORTC, ASCO Active, ASCO Active-junior or eligible to join ASCO)
- Include a statement of interest (up to 2 pages) which includes a description of your previous research background, how your experience makes you an ideal candidate for the Tutorial and how the tutorial's objectives meet or will assist you in meeting your research objectives.
- Provide a letter from your division director endorsing your current research plan and attenance at the meeting.
Submit all materials to
markerssymposium@asco.org by 5 pm Eastern on Aug. 15.
Leukemia & Lymphoma Society Specialized Center of Research Program
Letter of Intent Deadline: Nov. 1, 2008
More details The Marshall A. Lichtman Specialized Center of Research (SCOR) program was established to encourage multidisciplinary research focused on the prevention, diagnosis, or treatment of leukemia, lymphoma or myeloma. The program requires synergy among at least three research programs and these programs may be supported by scientific core laboratories. The program permits an application for a competitive renewal of the SCOR grant after five years depending on the progress shown. The program is organized to encourage the interaction of complementary sciences and the linkage of basic sciences to a translational research program. The center's maximal annual total cost, direct and indirect, cannot exceed $1.25 million. The aggregate costs over five years cannot exceed $6.25 million. The direct costs, if justified by the aggregate budget may be up to $1.042 million per year. The indirect or institutional costs cannot exceed 20 percent of the direct costs per year.
A Letter of Intent is due each year via proposalcentral by Nov. 1. Unlike The Leukemia & Lymphoma Society's (LLS) other research programs, SCOR applicants must be invited to submit a full application (after completing a LOI). The invitation to submit a full proposal will be announced by Dec. 31. The full application must be submitted by March 15.
ASCO Cancer Foundation Funding Opportunities
Deadline: Oct. 30, 2008
More information
Career Development Award: Provides funding to clinical investigators in their second, third, or fourth year of a faculty appointment to establish an independent clinical cancer research program. Total: $200,000 over three (3) years
Young Investigator Award: Provides funding to final-year fellows or first-year junior faculty, to encourage and promote quality research in clinical oncology. Total: $50,000 over one (1) year. NCI Cancer Prevention Fellowship Program
Deadline: Sept. 1
More Information
http://cancer.gov/prevention/pob The Cancer Prevention Fellowship Program at the National Cancer Institute is an excellent postdoctoral training opportunity that provides training in public health and mentored research with world-renown investigators at the NCI. The overarching goal of the CPFP is to provide a strong foundation for clinicians and scientists to train in the field of cancer prevention and control. As part of the program, we offer training toward an MPH degree at an accredited university during the first year, followed by mentored research with investigators at the NCI. Opportunities for research cut across a wide range of methodologies: basic science laboratory studies, clinical studies, epidemiologic studies, community intervention trials, studies of the biological and social aspects of behavior, policy studies, and research on the ethics of prevention. The CPFP provides competitive stipends, paid health insurance, reimbursement for moving expenses, and a travel allowance to attend scholarly meetings or training. The typical duration in the CPFP is 4 years (year 1: master’s degree; years 2-4: NCI Summer Curriculum in Cancer Prevention and mentored research). To be eligible, applicants must possess an MD, PhD, JD, or other doctoral degree in a related discipline (e.g., epidemiology, biostatistics, ethics, philosophy, or the biomedical, nutritional, public health, social, or behavioral sciences) or must be enrolled in an accredited doctoral degree program and fulfill all degree requirements by June 22, 2009. Foreign education must be comparable to that received in the United States. Applicants must also be US citizens or permanent residents. To learn more about this multidisciplinary program in cancer prevention, as well as eligibility requirements and application procedures please visit our website
http://cancer.gov/prevention/pob or contact
cpfpcoordinator@mail.nih.gov.
Week of July 22
National Lung Cancer Partnership Grants
Deadline: Sept. 2
More Information
The National Lung Cancer Partnership announces the opening of the application period for two award programs:
National Lung Cancer Partnership/ LUNGevity Foundation Research Grants for the promotion of understanding lung cancer risk, biology, and response to treatment. This grant program, administered by the National Lung Cancer Partnership and co-funded with the LUNGevity Foundation, is designed to provide seed money for promising novel research in lung cancer for faculty members at any point in their careers, performing research at any institution world-wide.
Two grants are available:
• One is specifically for research in the area of sex differences in lung cancer.
• One is for research pertaining to any facet of lung cancer.
Research Grants will be awarded for one or two years, for up to $50,000 per year ($100,000 maximum over 2 years).
National Lung Cancer Partnership Career Development Award for junior clinical and basic investigators involved in lung cancer etiology, prevention, and treatment at any U.S. or Canadian research institution. The National Lung Cancer Partnership’s goal is to create a critical mass of lung cancer researchers to ensure that basic and behavioral research discoveries are effectively translated into patient therapies to reduce lung cancer incidence, morbidity and mortality.
Applicants will be judged on the merits of their research proposal, career development plan, and research environment, among other factors. Applicants must be post-doctoral fellows, or within the first five years of a faculty appointment. Career Development Awards will be awarded for one or two years, for up to $50,000 per year ($100,000 maximum over 2 years).
For application eligibility and instructions for these Grant & Award competitions, please visit the National Lung Cancer Partnership website at www.NationalLungCancerPartnership.org.
Melanoma Research Foundation Research Grants
Deadline: August 18, 2008
More Information
The Melanoma Research Foundation (MRF) is pleased to announce its continued Research Award Programs. They offer both Established Investigator and Career Development Awards.
- The Established Investigator Award provides up to $100,000 per year for two years. The first Established Investigator Award was granted for 2006 as the Diana Ashby Award. The purpose of this grant is to encourage investigators to attempt high-risk, but potentially high-yield, melanoma research projects. For 2008, the foundation funded three projects.
- The MRF continues to support Career Development Awards as a means to encourage junior investigators to enter the field of melanoma research. These grants provide up to $50,000 per year for two years. For 2008, we funded eight second-year projects and six first-year projects.
The MRF is a national non-profit health organization. Its mission is (1) to fund RESEARCH to find more effective treatments and a cure for melanoma, (2) to EDUCATE clinicians, related healthcare providers, patients and families about melanoma prevention and treatments, and (3) to ADVOCATE on behalf of the melanoma patient and scientific community.
Colorado Clinical and Translational Science Institute K12 Research Scholar Award, University of Colorado Denver
Deadline: Aug. 1
More Information
What it is: An award to promote clinical and translational research career development. This program is designed to attract talented physicians, dentists, nurses, doctors of pharmacy, and allied health professionals to the challenges of clinical research. The goal of the CCTSI K12 Research Scholar award is for the grantee to ultimately obtain an individual career development award, or an independent investigator (i.e. R01) award. The research that is proposed in the application must be clinical or translational in nature. Visit the NIH website (www.nih.gov) for more information about NIH Career Development Awards, and definition of clinical and translational research.
Funding that it provides:
- Salary commensurate with 75% of full professional effort (50% or greater for those in the department of surgery), up to $73,000 per year ($94,900 including fringe benefits)
- $ 6000 for supplies per year
- $ 5000 for tuition and fees for advanced coursework
- $ 1000 for travel support per year
Support may continue for up to three years. Mentors also receive a stipend for their effort. Please see the CCTSIs website at http://ctsa1.uchsc.edu/Pages/K12Program for full details on how to apply.
Ellen Burnham, MD, CCTSI Associate K12 Program Director Ellen.Burnham@uchsc.edu or 303-315-1365.
American Association for Cancer Research Outstanding Achievement in Cancer Research Award
Deadline: October 15, 2008
More Information
Through the generous contribution of an anonymous donor, the AACR established this Award in 1979 to give recognition to a young investigator on the basis of meritorious achievement in cancer research. In accordance with the wishes of the donor, the recipient must be no more than 40 years of age by the time the award is received.
The winner of the 29th Annual AACR Award for Outstanding Achievement in Cancer Research will give a lecture during the AACR Annual Meeting 2009 in Denver, CO, USA (April 18-22, 2009.)
Selection of the Award winner will be made on the basis of the candidate's meritorious achievements in cancer research. No regard will be given to race, gender, nationality, or religious or political view.
Albert Szent-Gyorgyi Prize
Deadline: Sept. 30
More information www.asgprize.org
The National Foundation for Cancer Research (NFCR) is proud to announce that nominations are being accepted for the 4th Annual Albert Szent-Györgyi Prize for Progress in Cancer Research.
This international prize recognizes a distinguished individual who has demonstrated outstanding scientific achievement in the “war against cancer.
The winner of the prize:
- Receives a $25,000 cash prize.
- Is honored at the annual Albert Szent-Györgyi Prize for Progress in Cancer Research Award Dinner in New York City.
- Gets recognition from international media and press for their significant advancement in the field of cancer research, specifically through basic science research.
- Serves as the Chairman of the Albert Szent-Györgyi Prize Committee the following year.
Named after Dr. Albert Szent-Györgyi—the recipient of the 1937 Nobel Prize for Physiology and Medicine—this Prize extends his vision of pursuing a cure for cancer through innovation and collaboration. The Prize serves to stimulate Dr. Szent-Györgyi’s quest for a continued investment in pioneering breakthroughs and a deeper understanding of scientific concepts behind the genetics and molecular make-up of cancer.
NFCR is committed to upholding Dr. Szent-Györgyi’s vision of curing cancer through innovation and collaboration through this Prize to honor scientists who have made extraordinary progress in cancer research and focus attention on the wide variety of endeavors toward discoveries.
Visit www.ASGPrize.org for information about the Albert Szent-Györgyi Prize for Progress in Cancer Research.
Week of July 15: No announcements
Week of July 8, 2008
Sallie Rosen Kaplan Fellowship for Women in Basic, Clinical, Epidemiological Or Prevention Science
Deadline: Dec. 12
More Information: http://www.training.nih.gov/apps/publicForms/postdoctoral/forms/adIndex.aspx
The Sallie Rosen Kaplan Fellowship for Women Scientists in Cancer Research is made possible by a generous bequest to the Foundation for NIH (FNIH). This is a competitive program for postdoctoral fellows applying to train in any of the National Cancer Institute's intramural research settings, including basic, clinical, epidemiological, and prevention science.
The postdoctoral fellowship experience at the NCI can serve as a first postdoctoral training assignment, or offer more experienced postdoctoral scientists an opportunity to further their training in more advanced methods, to acquire new research capabilities, to make changes in the direction of their research, or to receive training in fundamental sciences and clinical disciplines for the purpose of enhancing the transfer of biotechnology to cancer clinical programs.
Program duration is normally 2 to 5 years. Fellows will be supported by a Cancer Research Training Award (CRTA), with an augmented stipend in the first year provided by the FNIH. The CRTA Fellowship stipend range is $46,200 to $78,000 commensurate with level of experience. Standard self and family health insurance is provided and high option coverage is available.
Candidates for the Sallie Rosen Kaplan Fellowship must be female, must possess a doctoral degree, and must have less than 5 years postdoctoral research experience. U.S. citizenship or U.S. permanent residency (green card) is required. Finalists for the Kaplan fellowship will be notified by March 2009 and winners announced by May 2009. To be eligible for the Sallie Rosen Kaplan Fellowship award, the starting date of any NCI fellowship must be no earlier than December 15, 2008. Applicants are required to apply online by December 12, 2008.
Questions concerning the Sallie Rosen Kaplan Fellowship may be addressed to Ms. Sandy Koeneman at koenemas@mail.nih.govor 301-496-0807.
AACR Henry Shepard Grants for Bladder Cancer Research
Deadline: Friday, July 25, 2008 at 12:00 noon, U.S. Eastern Time
More Information
Four Grants will be awarded.
These two-year Grants will provide up to $250,000 in total support for innovative cancer research projects designed to accelerate the discovery, development, and application of new agents to treat bladder cancer and/or for pre-clinical research with direct therapeutic intent.
Laboratory-based projects must present plans with clinical collaborators indicating how the work will be translated into the clinic. Similarly, clinical studies must show how the work was derived from basic preclinical work and how results will be channeled back to laboratory-based collaborators.
Independent investigators who are affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science anywhere in the world may apply. There are no geographic, national, or residency status restrictions. Pre- and Postdoctoral fellows are not eligible.
Application Submission: Online via proposalCENTRAL. Inquiries may be directed to Linda Stokes at awards@aacr.org.
Week of July 1, 2008
Cancer Research Institute Postdoctoral Fellowship Program
Deadline: October 1, 2008
More Information
The Irvington Institute Fellowship Program of the Cancer Research Institute, formerly the Cancer Research Institute Postdoctoral Fellowship Program, answers the need for more researchers in the field of cancer immunology. It supports qualified young scientists at leading universities and research centers around the world who wish to receive training in cancer immunology or general immunology.
The fellowship provides stipends of $40,000 for the first year, $42,000 for the second year and $44,000 for the third year. In addition, an allowance of $1,500 per year is allotted to the host institution for use at sponsor’s discretion to help pay for the fellow’s research supplies, travel to scientific meetings or health insurance. Stipends and institutional allowances are not permitted to cover administrative expenses. Payments are made monthly in U.S. currency to the host institution.
Wendy Will Case Cancer Fund, Inc.
Deadline: October 1st, 2008
More Information
Wendy Will Case died of cancer in November 1982, at the age of 39. In 1983, Wendy's family and friends established a fund to support promising researchers and help them establish "track records." To date, grants of over $2,500,000 have been made, mostly to researchers with innovative approaches. More than two-thirds have later received grants from NIH, NCI, ACS or other grantors.
The Case Fund Advisory Board is made of up some of the foremost authorities on cancer research in the United States . We invite you to submit your application keeping in mind the following information:
We do not consider grants for the continuation of projects previously funded or to researchers with substantial outstanding grants.
- We are primarily interested in, but not limited to, clinically related research.
- We consider applications for one-year grants only, with budgets of $30,000 or less.
- We will not fund the salary of the primary researcher. We will support assistants.
- We do not buy equipment - supplies only.
- We do not cover overhead costs such as rent, light, etc.
Click here to obtain a Grant Application Summary. The Grant Application Summary form must be completed in all respects. Attach additional sheets as necessary. Also, please submit the same proposal as you did to major United States funders (NIH, NCI, ACS, etc.), after not receiving a grant from them, with a reworked budget to reflect our limitations. Include all such agency evaluations with your proposal. Generally, we do not consider applications which have not been reviewed by one or more of these major agencies.
Closing dates for grant submissions are April 1 and October 1. Funding periods begin July 1 and January 1 of each year. Submit five copies of your proposal.
If you have any additional questions, please contact Joan Grogan via e-mail.
Week of June 24, 2008
Lustgarten Foundation for Pancreatic Cancer Research
Letter of Intent Deadline: July 31, 2008
More information
The goal of the RFP is to make rapid advances in the battle against pancreatic cancer through a combination of cutting edge technology and novel ideas. Grants must focus on adenocarcinoma of the pancreas. Applications will be accepted from individual investigators as well as from collaborating institutions. Grants will be awarded for a one-year period for a maximum amount of $100,000, of which no more than 10% can be used for indirect costs.
International Myeloma Foundation Research Grants
Deadline: September 2, 2008
More Information
2009 Brian D. Novis Research Award Junior Grant Application
The International Myeloma Foundation funds several research grants including the Brian D. Novis Research Award. These grants are provided through donations from private individuals, and are presented annually by the International Myeloma Foundation. These awards go to doctors/researchers doing work in the field of multiple myeloma. This year's awards will be in the amount of $50,000. The Brian D. Novis Award honors the IMF’s founder Brian Novis, who died of multiple myeloma in July of 1992. The International Myeloma Foundation is a non-profit organization whose mission is to improve the quality of life for myeloma patients while working toward prevention and a cure.
The qualifications for a candidate for the Brian D. Novis Research Award include the following:
- Completed postdoctoral studies or clinical fellowships not later than August 1 of the application year.
- Ability to devote a minimum of 50% of his or her time to the research project during the Award year.
2009 Brian D. Novis Research Award Senior Grant Application
The International Myeloma Foundation funds several research grants including the Brian D. Novis Research Award. These grants are provided through donations from private individuals, and are presented annually by the International Myeloma Foundation. These awards go to doctors/researchers doing work in the field of multiple myeloma. This year’s awards will be in the amount of $80,000. The Brian D. Novis Award honors the IMF’s founder Brian Novis, who died of multiple myeloma in July of 1992. The International Myeloma Foundation is a non-profit organization whose mission is to improve the quality of life for myeloma patients while working toward prevention and a cure.
These awards are targeted to established investigators with a track record in myeloma or related research, and are designed for projects which represent a different focus, direction or area of research from those in which they are currently funded. In most cases, these awards will be for pilot projects to obtain sufficient funding for larger applications from NIH or similar larger funding agencies.
Week of June 17, 2008
Lymphoma Research Foundation Post-Doctoral Fellowships and Clinical Investigator Career Development Awards
Deadline: Sept. 10
More Information: http://www.lymphoma.org/site/pp.asp?c=chKOI6PEImE&b=2267445 .
Post-Doctoral Fellowships
These two-year fellowships help attract the nation's best scientific talent to careers in lymphoma and allow them to pursue promising leads under the guidance of a Sponsor. Applicants must be affiliated with an institution in the U.S. or Canada. Up to 10 fellowships may be awarded, each at $50,000 in year one, and $55,000 in year two.
Clinical Investigator Career Development Awards
This three-year program (now with recently expanded eligibility) funds training of clinicians who will participate in developing new therapeutics and diagnostic tools for lymphoma. Clinicians will be trained to design and administer clinical studies and to take on primary responsibility for trial design, protocol development, IRB submission, and publication. A Career Development Plan and the commitment of a mentor are required as part of the grant application. Up to three CDAs will be awarded, each at a maximum of $75,000 per year for three years. Applicants must be licensed in the U.S. or Canada.
Breast Cancer Research Foundation-AACR Grant for Translational Breast Cancer Research
Application Deadline: July 9, 2008 at 12:00 noon, U.S. Eastern Time
Application submission: Online viaproposalCENTRAL
These two-year grants of up to $250,000 will be awarded to support innovative cancer research projects designed to accelerate the discovery, development, and application of new agents to treat breast cancer and/or for pre-clinical research with direct therapeutic intent. Open to independent investigators only. Three grants will be presented. Click here for program guidelines and application instructions.
Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research
Nomination Deadline: July 10, 2008at 4:00 p.m., U.S. Eastern Time
Nomination submission: awards@aacr.org
The AACR is seeking nominations for the inaugural Susan G. Komen for the Cure AACR Outstanding Investigator Award for Breast Cancer Research. This Award will recognize an investigator whose novel and significant work has had or may have a far-reaching impact on the etiology, detection, diagnosis, treatment, or prevention of breast cancer. Such work may involve any discipline across the continuum of biomedical research, including basic, translational, clinical, and epidemiological studies.
This Award has been developed to honor investigators relatively early in their careers; thus, the recipient must be no more than 50 years of age at the time the Award is received.
The winner will receive an honorarium of $10,000 and deliver a 30-minute lecture during the San Antonio Breast Cancer Symposium, to be held December 10-14, 2008, at the Henry B. Gonzales Convention Center in San Antonio, TX . Travel support is provided.
For more informationand nomination instructions, please click here.
Week of June 10, 2008
JP McCarthy Fund 2008 Developmental Grant
Deadline: Aug. 15
More Information
Objective: To strengthen the base of high-quality research in hematological diseases in major research centers. Basic, translational and clinical research will be considered for funding. $25,000 per year for two years. Assistant, associate and full professors may apply.
Funderburg Research Scholar Award in Gastric Biology Related to Cancer
Deadline: Sept. 30
More Information
This grant of $50,000 per year for two years (total $100,000) is awarded to an established investigator working on novel approaches in gastric cancer, including the fields of gastric mucosal cell biology; regeneration and regulation of cell growth (not as they relate to peptic ulcer disease or repair); inflammation (including Helicobacter pylori) as precancerous lesions; genetics of gastric carcinoma; oncogenes in gastric epithelial malignancies; epidemiology of gastric cancer; etiology of gastric epithelial malignancies; or clinical research in the diagnosis or treatment of gastric carcinoma.